These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23337447)

  • 1. [Resistant hypertension: from prevention to renal denervation].
    Ruilope LM; Arribas F
    Med Clin (Barc); 2013 Jul; 141(1):27-8. PubMed ID: 23337447
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation.
    Wang Y
    Int J Cardiol; 2014 Oct; 176(3):1262-3. PubMed ID: 25115259
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal denervation therapy for hypertension.
    Thukkani AK; Bhatt DL
    Circulation; 2013 Nov; 128(20):2251-4. PubMed ID: 24218440
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
    Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal sympathetic denervation in refractory hypertension].
    Sans Atxer L; Oliveras A
    Med Clin (Barc); 2013 Mar; 140(6):263-5. PubMed ID: 23276614
    [No Abstract]   [Full Text] [Related]  

  • 6. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension.
    Gewirtz JR; Bisognano JD
    Cardiol J; 2011; 18(1):97-102. PubMed ID: 21305496
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.
    Prochnau D; Figulla HR; Surber R
    Expert Rev Med Devices; 2013 Mar; 10(2):247-56. PubMed ID: 23480093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal denervation - a novel therapeutic option for resistant hypertension?].
    Ritter A; Sudano Noll I; Suter PM
    Praxis (Bern 1994); 2014 Oct; 103(20):1169-78. PubMed ID: 25270745
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: renal sympathetic denervation: a true lack of efficacy, or the victim of a "perfect storm"?
    Baker NC; Waksman R
    Cardiovasc Revasc Med; 2014 Mar; 15(2):61-2. PubMed ID: 24684755
    [No Abstract]   [Full Text] [Related]  

  • 11. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal denervation a new treatment option in resistant arterial hypertension].
    Himmel F; Bode F; Schunkert H; Weil J
    Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation in hypertension: simplicity, or complexity?
    Lantelme P; Courand PY; Bricca G
    Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
    [No Abstract]   [Full Text] [Related]  

  • 14. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated ESH position paper on interventional therapy of resistant hypertension.
    Schmieder RE; Redon J; Grassi G; Kjeldsen SE; Mancia G; Narkiewicz K; Parati G; Ruilope L; van de Borne P; Tsioufis C;
    EuroIntervention; 2013 May; 9 Suppl R():R58-66. PubMed ID: 23732157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
    Bunte MC; Infante de Oliveira E; Shishehbor MH
    JACC Cardiovasc Interv; 2013 Jan; 6(1):1-9. PubMed ID: 23266234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistant hypertension: is renal denervation the current treatment of choice?
    Reddi AS
    Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S; Andersson B; Manhem K; Haraldsson I; Rundqvist B
    Blood Press; 2014 Aug; 23(4):228-32. PubMed ID: 24432803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SYMPLICITY: not all that simple.
    Luft FC
    Kidney Int; 2014 May; 85(5):999-1001. PubMed ID: 24786869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.